Vivek N. Prachand to Stomach Neoplasms
This is a "connection" page, showing publications Vivek N. Prachand has written about Stomach Neoplasms.
Connection Strength
0.706
-
Evaluation of the Association of Perioperative UGT1A1 Genotype-Dosed gFOLFIRINOX With Margin-Negative Resection Rates and Pathologic Response Grades Among Patients With Locally Advanced Gastroesophageal Adenocarcinoma: A Phase 2 Clinical Trial. JAMA Netw Open. 2020 02 05; 3(2):e1921290.
Score: 0.148
-
Optimal management of gastric cancer: results from an international RAND/UCLA expert panel. Ann Surg. 2014 Jan; 259(1):102-8.
Score: 0.097
-
Processes of care in the multidisciplinary treatment of gastric cancer: results of a RAND/UCLA expert panel. JAMA Surg. 2014 Jan; 149(1):18-25.
Score: 0.097
-
What provider volumes and characteristics are appropriate for gastric cancer resection? Results of an international RAND/UCLA expert panel. Surgery. 2013 Nov; 154(5):1100-9.
Score: 0.095
-
Defining surgical quality in gastric cancer: a RAND/UCLA appropriateness study. J Am Coll Surg. 2013 Aug; 217(2):347-57.e1.
Score: 0.092
-
Predictors of unsuccessful laparoscopic resection of gastric submucosal neoplasms. J Gastrointest Surg. 2013 Feb; 17(2):244-55; discussion 255-6.
Score: 0.090
-
A RAND/UCLA appropriateness study of the management of familial gastric cancer. Ann Surg Oncol. 2013 Feb; 20(2):533-41.
Score: 0.088